EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Postbiotics from Lacticaseibacillus rhamnosus IOB820 Combat Obesity in HFD Mice by Modulating Gut Microbiota and Enhancing SCFA Production

Xiaomin Feng iD, Hanlu Li, Jianxia Tian, Xuemei Han, Wu Liang, Feiliang Zhong, Xuegang Luo

Nutrients · 11.11.2025 · 17 (22) · 3525

DOI: 10.3390/nu17223525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.11.2025. Verfasst von Xiaomin Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, College of Biotechnology, Tianjin University of Science and Tech…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Obesity, Diet, High-Fat, Lacticaseibacillus rhamnosus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Tianjin University of Science and Technology Excellent Doctoral Dissertation Innovation Funding Project, the Jinan Innovation Team Project, the Tianjin Science and Technology Achievement Transfer and Transformation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate whether Lacticaseibacillus rhamnosus (L. rhamnosus) IOB820 and its postbiotics can combat high-fat diet (HFD)-induced obesity, improve metabolic parameters, and modulate gut microbiota and systemic inflammation in a mouse model.

Methods

Seventy 4-week-old male C57BL/6J mice were divided into a normal diet group, an HFD control group, two postbiotic dose groups, two live bacteria dose groups, and an orlistat control group. After 10 weeks of intervention with live L. rhamnosus IOB820 or its postbiotics, body weight, metabolic parameters (blood glucose, lipid profile, hepatic steatosis), pro- and anti-inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-10), gut microbiota composition (α, β diversity and taxonomic shifts), and fecal short-chain fatty acid (SCFA) levels were assessed.

Results

Both live L. rhamnosus IOB820 and its postbiotics significantly alleviated HFD-induced weight gain and improved metabolic outcomes. The treatments also reduced systemic inflammation, as indicated by decreased levels of TNF-α, IL-6, and IL-1β and elevated IL-10. These effects were accompanied by restoration of gut microbial diversity, enrichment of beneficial taxa, and increased fecal SCFA concentrations.

Conclusions

L. rhamnosus IOB820 and its postbiotics effectively mitigate obesity and related metabolic disturbances in HFD-fed mice. Their beneficial effects are likely mediated through modulation of gut microbiota composition and enhancement of SCFA-driven anti-inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeObesityDiet, High-FatLacticaseibacillus rhamnosusProbioticsFatty Acids, VolatileAnimalsMaleMice, Inbred C57BLMiceCytokinesFecesInflammationDisease Models, Animal

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosus IOB820gut microbiotaobesityprobioticsshort-chain fatty acids

Substanzen

Fatty Acids, VolatileCytokines

Autor:innen und Institutionen

  • Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
  • Tianjin Key Laboratory of Edible Probiotics, Tianjin 300301, China.

ORCID-Profile: Xiaomin Feng

Förderung

  • the Tianjin University of Science and Technology Excellent Doctoral Dissertation Innovation Funding Project
  • the Jinan Innovation Team Project
  • the Tianjin Science and Technology Achievement Transfer and Transformation Project
  • the Tianjin Applied Basic Research Project Enterprise Science and Technology Special Agent Project
  • the Chongqing Special Project for Technology Innovation and Application Development in Rural Revitalization
  • Tianjin University of Science and Technology Excellent Doctoral Dissertation Innovation Funding Project
  • Jinan Innovation Team Project
  • Tianjin Science and Technology Achievement Transfer and Transformation Project

Zitieren

APA

Feng, X., Li, H., Tian, J., Han, X., Liang, W., Zhong, F., & Luo, X. (2025). Postbiotics from Lacticaseibacillus rhamnosus IOB820 Combat Obesity in HFD Mice by Modulating Gut Microbiota and Enhancing SCFA Production. Nutrients, 17(22), 3525. https://doi.org/10.3390/nu17223525

Vancouver

Feng X, Li H, Tian J, Han X, Liang W, Zhong F, et al. Postbiotics from Lacticaseibacillus rhamnosus IOB820 Combat Obesity in HFD Mice by Modulating Gut Microbiota and Enhancing SCFA Production. Nutrients. 2025;17(22):3525. doi:10.3390/nu17223525

BibTeX
@article{Feng2025,
  author = {Feng, Xiaomin and Li, Hanlu and Tian, Jianxia and Han, Xuemei and Liang, Wu and Zhong, Feiliang and Luo, Xuegang},
  title = {Postbiotics from Lacticaseibacillus rhamnosus IOB820 Combat Obesity in HFD Mice by Modulating Gut Microbiota and Enhancing SCFA Production},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {22},
  pages = {3525},
  doi = {10.3390/nu17223525}
}
Kostenlos starten →